Literature DB >> 12960257

Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells.

Claire Chougnet1.   

Abstract

Cellular interactions between antigen-presenting cells and activated CD4+ T cells are central to the regulation of adaptive immunity. Among the many receptor-ligand pairs involved, the critical importance of CD40-CD40 Ligand (CD40L) interactions has been demonstrated in many experimental systems. Dysregulation of antigen-presenting cell function is a hallmark of HIV-associated defects in cell-mediated immunity. Much evidence suggests a mechanistic role for defective CD40-CD40L interactions in such a defect. Consistent with this hypothesis, the capacity to upregulate CD40L on purified CD4+ T cells becomes progressively impaired in HIV infection, in parallel with the progression of clinical immunosuppression. The mechanisms underlying CD40L dysregulation in HIV infection remain unknown. Because CD40L expression is tightly regulated (transcriptionally, post-transcriptionally and post-translationally), HIV may interfere at several levels. However, a transcriptional defect in CD40L expression, mediated by the engagement of CD4 by HIV gp120, appears to play a primary role. Clear elucidation of mechanism may well lead to the development of novel immunotherapeutic approaches to HIV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960257     DOI: 10.1189/jlb.0403171

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.

Authors:  Enrique Espinosa; Christopher E Ormsby; Gustavo Reyes-Terán; Robert Asaad; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.

Authors:  Alice M Nyakeriga; Jun Ying; Norah J Shire; Carl J Fichtenbaum; Claire A Chougnet
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

3.  Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions.

Authors:  Rui Zhang; Jeffrey D Lifson; Claire Chougnet
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

4.  Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.

Authors:  Nicole S Harhaj; Branislava Janic; Juan C Ramos; William J Harrington; Edward W Harhaj
Journal:  Virology       Date:  2007-01-26       Impact factor: 3.616

5.  B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus.

Authors:  Arpita Choudhury; Philip L Cohen; Robert A Eisenberg
Journal:  Clin Immunol       Date:  2010-04-08       Impact factor: 3.969

6.  Expression of CD154 by a simian immunodeficiency virus vector induces only transitory changes in rhesus macaques.

Authors:  Vida L Hodara; M Cristina Velasquillo; Laura M Parodi; Luis D Giavedoni
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.

Authors:  Liguo Niu; James M Termini; Saravana K Kanagavelu; Sachin Gupta; Morgane M Rolland; Viraj Kulkarni; George N Pavlakis; Barbara K Felber; James I Mullins; Margaret A Fischl; Geoffrey W Stone
Journal:  Vaccine       Date:  2011-01-15       Impact factor: 3.641

8.  Maternal HIV is associated with reduced growth in the first year of life among infants in the Eastern region of Ghana: the Research to Improve Infant Nutrition and Growth (RIING) Project.

Authors:  Anna Lartey; Grace S Marquis; Robert Mazur; Rafael Perez-Escamilla; Lucy Brakohiapa; William Ampofo; Daniel Sellen; Seth Adu-Afarwuah
Journal:  Matern Child Nutr       Date:  2012-08-20       Impact factor: 3.092

9.  A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individuals.

Authors:  Matthew Morrow; Antonio Valentin; Richard Little; Robert Yarchoan; George N Pavlakis
Journal:  AIDS Res Hum Retroviruses       Date:  2008-04       Impact factor: 2.205

10.  HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.

Authors:  Jason V Baker; Jacqueline Neuhaus; Daniel Duprez; Matthew Freiberg; Jose I Bernardino; Andrew D Badley; Daniel E Nixon; Jens D Lundgren; Russell P Tracy; James D Neaton
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.